Your browser doesn't support javascript.
loading
Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.
Nilsson, Emelie; Wetterholm, Erik; Syk, Ingvar; Thorlacius, Henrik; Rönnow, Carl-Fredrik.
Affiliation
  • Nilsson E; Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Wetterholm E; Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Syk I; Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Thorlacius H; Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Rönnow CF; Department of Clinical Sciences, Division of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.
BJS Open ; 8(3)2024 May 08.
Article de En | MEDLINE | ID: mdl-38869239
ABSTRACT

BACKGROUND:

Endoscopic resection of T1 colon cancer (CC) is currently limited by guidelines related to risk of lymph node metastases. However, clinical outcome following endoscopic and surgical resection is poorly investigated.

METHOD:

A retrospective multicentre national cohort study was conducted on prospectively collected data from the Swedish colorectal cancer registry on all non-pedunculated T1 CC patients undergoing surgical and endoscopic resection between 2009 and 2021. Patients were categorized on the basis of deep submucosal invasion (Sm2-3), lymphovascular invasion (LVI), poor tumour differentiation, and R1/Rx into low- and high-risk cases. The primary outcomes of interest were recurrence rates and disease-free interval (DFI, defined as time from treatment to date of recurrence) according to resection methods and risk factors (sex, age at diagnosis, histologic grade, LVI, perineural invasion, mucinous subtype, submucosal invasion, tumour location, resection margin and nodal positivity in the surgical group).

RESULTS:

In total, 1805 patients undergoing endoscopic (488) and surgical (1317) resection with 60.0 months median follow-up were included. Recurrence occurred in 18 (3.7%) endoscopically and 48 (3.6%) surgically resected patients. Adjuvant treatment was administered in 7.4% and 0.2% of the cases respectively in the surgical and endoscopically treated patients. Five-year DFI was 95.6% after endoscopic and 96.2% after surgical resection, with no significant difference when adjusting for confounding factors (HR 1.03, 95% c.i. 0.56 to 1.91, P = 0.920). There were no statistically significant differences in recurrence comparing endoscopic (1.7%) versus surgical (3.6%) low-risk and endoscopic (5.4%) versus surgical (3.8%) high-risk cases. LVI was the only significant risk factor for recurrence in multivariate Cox regression (HR 3.73, 95% c.i. 1.76 to 7.92, P < 0.001).

CONCLUSIONS:

This study shows no difference in recurrence after endoscopic and surgical resection in high-risk T1 CC. Although it was not possible to match groups according to treatment, the multivariate analysis showed that lymphovascular invasion was the only independent risk factor for recurrence.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Enregistrements / Tumeurs du côlon / Récidive tumorale locale Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: BJS Open Année: 2024 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Enregistrements / Tumeurs du côlon / Récidive tumorale locale Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: BJS Open Année: 2024 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni